Arthritis drug shows promise against respiratory distress caused by COVID-19
Thursday, May 7, 2020 - 18:40
in Health & Medicine
Anakinra, a drug developed to treat rheumatoid arthritis might help patients who have developed acute respiratory distress syndrome caused by COVID-19, a small study published by The Lancet Rheumatology has found.